[
    [
        {
            "time": "",
            "original_text": "华大基因(300676.SZ)：华大数据极肠癌辅助诊断产品获欧盟CE准入资质",
            "features": {
                "keywords": [
                    "华大基因",
                    "肠癌辅助诊断",
                    "欧盟CE",
                    "准入资质"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华大基因(300676.SZ)：华大数据极肠癌辅助诊断产品获欧盟CE准入资质",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "华大基因：控股子公司产品获得欧盟CE准入资质",
            "features": {
                "keywords": [
                    "华大基因",
                    "子公司",
                    "欧盟CE",
                    "准入资质"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华大基因：控股子公司产品获得欧盟CE准入资质",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "早间公告：华大基因子公司产品获得欧盟CE准入资质",
            "features": {
                "keywords": [
                    "华大基因",
                    "子公司",
                    "欧盟CE",
                    "准入资质"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "早间公告：华大基因子公司产品获得欧盟CE准入资质",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华大基因：子公司肠癌辅助诊断产品获欧盟CE准入资质",
            "features": {
                "keywords": [
                    "华大基因",
                    "子公司",
                    "肠癌辅助诊断",
                    "欧盟CE",
                    "准入资质"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华大基因：子公司肠癌辅助诊断产品获欧盟CE准入资质",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "华大基因(300676.SZ)子公司一项肠癌辅助诊断产品获欧盟CE准入资质",
            "features": {
                "keywords": [
                    "华大基因",
                    "子公司",
                    "肠癌辅助诊断",
                    "欧盟CE",
                    "准入资质"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华大基因(300676.SZ)子公司一项肠癌辅助诊断产品获欧盟CE准入资质",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]